§ 54.1-3454 Schedule V
The controlled substances listed in this section are included in Schedule V:
1. Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which also contains one or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone: Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams; Not more than 100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams; Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams; Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit; Not more than 100 milligrams of opium per 100 milliliters or per 100 grams; Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit. The Board may except by regulation any compound, mixture, or preparation containing any depressant substance listed in subdivision 1 from the application of all or any part of this chapter and such substances so excepted may be dispensed pursuant to § 54.1-3416.
2. Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers: Pyrovalerone.
3. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts: Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide) (also referred to as BRV; UCB-34714; Briviact); Ezogabine [N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester]-2779; Gabapentin [1-(aminomethyl)cyclohexaneacetic acid]; Ganaxolone; Lacosamide [(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide]; Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide]; Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid].
History
This law was first created in 1972. The record of its establishment is cataloged in chapter 798 of that year’s edition of “Acts of Assembly,” the annual state publication listing all changes made to the Code of Virginia in that year. Unfortunately, the 1972 “Acts” aren’t available online. It has been modified 16 times. Those modifications are cataloged by “The Acts of Assembly,” a state publication, by year and chapter. Those modifications that can be read on the General Assembly’s website will be linked accordingly. Those modifications are as follows: in 1976, chapter 614; in 1977, chapter 302; in 1979, chapter 387; in 1984, chapter 186; in 1986, chapter 463; in 1988, chapter 765; in 1992, chapter 737; in 1994, chapter 763; in 2003, chapter 640; in 2006, chapter 346; in 2010, chapter 423; in 2012, chapter 541; in 2017, chapter 612; in 2019, chapter 214; in 2022, chapters 114 and 115; in 2024, chapters 62 and 228.
1972, c. 798, § 54-524.84:12; 1976, c. 614; 1977, c. 302; 1979, c. 387; 1984, c. 186; 1986, c. 463; 1988, c. 765; 1992, c. 737; 1994, c. 763; 2003, c. 640; 2006, c. 346; 2010, c. 423; 2012, c. 541; 2017, c. 612; 2019, c. 214; 2022, cc. 114, 115; 2024, cc. 62, 228.